Varicella zoster immune globulin Pregnancy and Breastfeeding Warnings
Brand names: VariZIG
Medically reviewed by Drugs.com. Last updated on Aug 16, 2023.
Varicella zoster immune globulin Pregnancy Warnings
Use only if clearly needed.
AU TGA pregnancy category: Exempt
US FDA pregnancy category: C
Comments:
-There is no data on use in pregnant women to know this drugs risks, including the risk of fetal harm or reproductive effects.
Animal studies have not been conducted. There are no controlled data in human pregnancy.
AU Exempt: Medications exempted from pregnancy classification are not absolutely safe for use in pregnancy in all circumstances. Some exempted medicines, for example the complementary medicine, St John's Wort, may interact with other medicines and induce unexpected adverse effects in the mother and/or fetus.
US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
Varicella zoster immune globulin Breastfeeding Warnings
Caution is recommended.
Excreted into human milk: Unknown
Excreted into animal milk: Data not available
See also
References for pregnancy information
- TGA. Therapeutic Goods Administration. Australian Drug Evaluation Committee (2010) Prescribing medicines in pregnancy: an Australian categorisation of risk of drug use in pregnancy. http://www.tga.gov.au/docs/html/medpreg.htm
- (2019) "Product Information. Varizig (varicella zoster immune globulin)." Cangene Corporation
References for breastfeeding information
- (2019) "Product Information. Varizig (varicella zoster immune globulin)." Cangene Corporation
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
